Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends

• Published in: Seminars in nuclear medicine Vol. 54; no. 5; pp. 648 - 657
• Main Authors: Miller, Robert J.H., Slomka, Piotr J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2024
• ISSN: 0001-2998; 1558-4623; 1558-4623
• DOI: 10.1053/j.semnuclmed.2024.02.005

Myocardial perfusion imaging (MPI), using either single photon emission computed tomography (SPECT) or positron emission tomography (PET), is one of the most commonly ordered cardiac imaging tests, with prominent clinical roles for disease diagnosis and risk prediction. Artificial intelligence (AI) could potentially play a role in many steps along the typical MPI workflow, from image acquisition through to clinical reporting and risk estimation. AI can be utilized to improve image quality, reducing radiation exposure and image acquisition times. Once images are acquired, AI can help optimize motion correction and image registration during image reconstruction or provide direct image attenuation correction. Utilizing these image sets, AI can segment a number of anatomic features from associated computed tomographic imaging or even generate synthetic attenuation imaging. Lastly, AI may play an important role in disease diagnosis or risk prediction by combining the large number of potentially important clinical, stress, and imaging-related variables. This review will focus on the most recent developments in the field, providing clinicians and researchers with a timely update on the field. Additionally, it will discuss future trends including applications of AI during multiple points of the typical MPI workflow to maximize clinical utility and methods to maximize the information that can be obtained from hybrid imaging.